Pharming Group N.V. (PHAR) Net margin 2019–2025
Pharming Group N.V. (PHAR) net profit margin by fiscal year — reported net income divided by reported revenue.
0.8%FY2025 · since FY2019: 21.4% → 0.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 0.8% | +4.7 pp |
| FY2024 | -4.0% | +0.3 pp |
| FY2023 | -4.3% | -10.9 pp |
| FY2022 | 6.7% | -1.4 pp |
| FY2021 | 8.0% | -9.7 pp |
| FY2020 | 17.8% | -3.6 pp |
| FY2019 | 21.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More PHAR financial trends
PHAR RevenuePHAR Net incomePHAR Gross profitPHAR Gross marginPHAR Operating incomePHAR Operating marginPHAR Operating cash flowPHAR Free cash flowPHAR Capital expendituresPHAR Return on equityPHAR Stock buybacksPHAR Dividends paidPHAR Total assetsPHAR Total liabilitiesPHAR Shareholders’ equityPHAR overview →